George Scangos (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "George Scangos" in English language version.

refsWebsite

Global rank English rank

4nih.gov

4^th place

3doi.org

2^nd place

3xconomy.com

low place

6,978^th place

2harvard.edu

18^th place

17^th place

2semanticscholar.org

11^th place

8^th place

1biopharmadive.com

low place

1bizjournals.com

407^th place

241^st place

1biogen.com

low place

1pharmavoice.com

low place

1web.archive.org

1^st place

1biospace.com

low place

7,595^th place

1greekreporter.com

3,698^th place

2,659^th place

1statnews.com

8,771^st place

5,253^rd place

biogen.com

investors.biogen.com

"Biogen Idec Names George Scangos Chief Executive Officer". Retrieved April 5, 2023.

biopharmadive.com

Fidler, Ben (January 25, 2023). "Veteran biotech leader George Scangos to step down as Vir CEO". BioPharma Dive. Retrieved April 5, 2023.

biospace.com

"Vir Biotechnology Announces Retirement of CEO George Scangos, Ph.D.; Appoints Marianne De Backer, MSc, Ph.D., MBA, as Successor". BioSpace. January 25, 2023.

bizjournals.com

"George Scangos". www.bizjournals.com.

doi.org

Scangos, Georg A.; Reiner, Albey Mahesh (March 1, 1979). "A unique pattern of toxic synthesis in pentitol catabolism: Implications for evolution". Journal of Molecular Evolution. 12 (3): 189–195. Bibcode:1979JMolE..12..189S. doi:10.1007/BF01732338. PMID 374747. S2CID 34473235.
Gordon, J W; Scangos, G A; Plotkin, D J; Barbosa, J A; Ruddle, F H (December 1980). "Genetic transformation of mouse embryos by microinjection of purified DNA". Proceedings of the National Academy of Sciences. 77 (12): 7380–7384. Bibcode:1980PNAS...77.7380G. doi:10.1073/pnas.77.12.7380. PMC 350507. PMID 6261253.
Mitchell, Peter (January 1, 2011). "Biogen Idec restructures, sharpens neurology focus". Nature Biotechnology. 29 (1): 7–8. doi:10.1038/nbt0111-7. PMID 21221080. S2CID 205264959.

greekreporter.com

Kampouris, Nick (March 9, 2020). "Greek-American Scientist Heads Global Campaign for Coronavirus Treatment". Greek Reporter. Retrieved April 5, 2023.

harvard.edu

ui.adsabs.harvard.edu

Scangos, Georg A.; Reiner, Albey Mahesh (March 1, 1979). "A unique pattern of toxic synthesis in pentitol catabolism: Implications for evolution". Journal of Molecular Evolution. 12 (3): 189–195. Bibcode:1979JMolE..12..189S. doi:10.1007/BF01732338. PMID 374747. S2CID 34473235.
Gordon, J W; Scangos, G A; Plotkin, D J; Barbosa, J A; Ruddle, F H (December 1980). "Genetic transformation of mouse embryos by microinjection of purified DNA". Proceedings of the National Academy of Sciences. 77 (12): 7380–7384. Bibcode:1980PNAS...77.7380G. doi:10.1073/pnas.77.12.7380. PMC 350507. PMID 6261253.

nih.gov

pubmed.ncbi.nlm.nih.gov

Scangos, Georg A.; Reiner, Albey Mahesh (March 1, 1979). "A unique pattern of toxic synthesis in pentitol catabolism: Implications for evolution". Journal of Molecular Evolution. 12 (3): 189–195. Bibcode:1979JMolE..12..189S. doi:10.1007/BF01732338. PMID 374747. S2CID 34473235.
Gordon, J W; Scangos, G A; Plotkin, D J; Barbosa, J A; Ruddle, F H (December 1980). "Genetic transformation of mouse embryos by microinjection of purified DNA". Proceedings of the National Academy of Sciences. 77 (12): 7380–7384. Bibcode:1980PNAS...77.7380G. doi:10.1073/pnas.77.12.7380. PMC 350507. PMID 6261253.
Mitchell, Peter (January 1, 2011). "Biogen Idec restructures, sharpens neurology focus". Nature Biotechnology. 29 (1): 7–8. doi:10.1038/nbt0111-7. PMID 21221080. S2CID 205264959.

ncbi.nlm.nih.gov

Gordon, J W; Scangos, G A; Plotkin, D J; Barbosa, J A; Ruddle, F H (December 1980). "Genetic transformation of mouse embryos by microinjection of purified DNA". Proceedings of the National Academy of Sciences. 77 (12): 7380–7384. Bibcode:1980PNAS...77.7380G. doi:10.1073/pnas.77.12.7380. PMC 350507. PMID 6261253.

pharmavoice.com

Ribbink, Kim (March 25, 2009). "Dr. George Scangos: Gene Excellence". PharmaVoice. Retrieved April 6, 2023.

semanticscholar.org

api.semanticscholar.org

Scangos, Georg A.; Reiner, Albey Mahesh (March 1, 1979). "A unique pattern of toxic synthesis in pentitol catabolism: Implications for evolution". Journal of Molecular Evolution. 12 (3): 189–195. Bibcode:1979JMolE..12..189S. doi:10.1007/BF01732338. PMID 374747. S2CID 34473235.
Mitchell, Peter (January 1, 2011). "Biogen Idec restructures, sharpens neurology focus". Nature Biotechnology. 29 (1): 7–8. doi:10.1038/nbt0111-7. PMID 21221080. S2CID 205264959.

statnews.com

Mast, Jason (January 25, 2023). "Vir CEO George Scangos to retire, after pandemic success". STAT.

web.archive.org

Fidler, Ben (July 21, 2016). "With Biogen at a Crossroads, CEO Scangos to Step Down | Xconomy". Xconomy Boston. Archived from the original on February 2, 2017. Retrieved April 6, 2023.

xconomy.com

Timmerman, Luke (August 31, 2011). "George Scangos, the Boy From Working Class Boston, on His Road Back to Lead Biogen Idec". Xconomy Boston. Retrieved April 6, 2023.
Fidler, Ben (July 21, 2016). "With Biogen at a Crossroads, CEO Scangos to Step Down | Xconomy". Xconomy Boston. Archived from the original on February 2, 2017. Retrieved April 6, 2023.
Timmerman, Luke (June 16, 2011). "Biogen Idec CEO on Move Back to Cambridge: "We're Working on It"". Xconomy Boston. Retrieved April 6, 2023.